Serveur d'exploration sur Heinrich Schütz

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells

Identifieur interne : 000D73 ( Main/Corpus ); précédent : 000D72; suivant : 000D74

Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells

Auteurs : Nicholas M. Morton ; Rolf P. De Groot ; Michael A. Cawthorne ; Valur Emilsson

Source :

RBID : ISTEX:D7F2399CD8FED943471BB11ED805B8AFB48B84A4

Abstract

Interleukin-1β (IL-1β) is a potent inflammatory cytokine involved in type 1 diabetes and acts through defined IL-1β signaling pathways. In the present work we describe induction of DNA binding activity to signal transducer and activator of transcription (STAT) in response to IL-1β in clonal insulin-secreting cells. Moreover, IL-1β activates a short isoform of STAT-3 that potently stimulates transcription. Immunoprecipitation studies reveal an interaction between the activated STAT-3 and the IL-1 receptor accessory protein indicating an association between the two signaling pathways. This may be a novel point of transduction cross talk and an additional mechanism utilised by IL-1β in the pancreatic β-cell during the process of type 1 diabetes.

Url:
DOI: 10.1016/S0014-5793(98)01623-8

Links to Exploration step

ISTEX:D7F2399CD8FED943471BB11ED805B8AFB48B84A4

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells</title>
<author>
<name sortKey="Morton, Nicholas M" sort="Morton, Nicholas M" uniqKey="Morton N" first="Nicholas M." last="Morton">Nicholas M. Morton</name>
<affiliation>
<mods:affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Groot, Rolf P" sort="De Groot, Rolf P" uniqKey="De Groot R" first="Rolf P." last="De Groot">Rolf P. De Groot</name>
<affiliation>
<mods:affiliation>Department of Pulmonary Diseases, University Hospital Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cawthorne, Michael A" sort="Cawthorne, Michael A" uniqKey="Cawthorne M" first="Michael A." last="Cawthorne">Michael A. Cawthorne</name>
<affiliation>
<mods:affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Emilsson, Valur" sort="Emilsson, Valur" uniqKey="Emilsson V" first="Valur" last="Emilsson">Valur Emilsson</name>
<affiliation>
<mods:affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Corresponding author. Fax: (44) (1280) 822245. E-mail: valur.emilsson@buckingham.ac.uk</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D7F2399CD8FED943471BB11ED805B8AFB48B84A4</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0014-5793(98)01623-8</idno>
<idno type="url">https://api.istex.fr/document/D7F2399CD8FED943471BB11ED805B8AFB48B84A4/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000D73</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells</title>
<author>
<name sortKey="Morton, Nicholas M" sort="Morton, Nicholas M" uniqKey="Morton N" first="Nicholas M." last="Morton">Nicholas M. Morton</name>
<affiliation>
<mods:affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Groot, Rolf P" sort="De Groot, Rolf P" uniqKey="De Groot R" first="Rolf P." last="De Groot">Rolf P. De Groot</name>
<affiliation>
<mods:affiliation>Department of Pulmonary Diseases, University Hospital Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cawthorne, Michael A" sort="Cawthorne, Michael A" uniqKey="Cawthorne M" first="Michael A." last="Cawthorne">Michael A. Cawthorne</name>
<affiliation>
<mods:affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Emilsson, Valur" sort="Emilsson, Valur" uniqKey="Emilsson V" first="Valur" last="Emilsson">Valur Emilsson</name>
<affiliation>
<mods:affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Corresponding author. Fax: (44) (1280) 822245. E-mail: valur.emilsson@buckingham.ac.uk</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">FEBS Letters</title>
<title level="j" type="abbrev">FEBS</title>
<idno type="ISSN">0014-5793</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1998">1998</date>
<biblScope unit="volume">442</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="57">57</biblScope>
<biblScope unit="page" to="60">60</biblScope>
</imprint>
<idno type="ISSN">0014-5793</idno>
</series>
<idno type="istex">D7F2399CD8FED943471BB11ED805B8AFB48B84A4</idno>
<idno type="DOI">10.1016/S0014-5793(98)01623-8</idno>
<idno type="PII">S0014-5793(98)01623-8</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0014-5793</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Interleukin-1β (IL-1β) is a potent inflammatory cytokine involved in type 1 diabetes and acts through defined IL-1β signaling pathways. In the present work we describe induction of DNA binding activity to signal transducer and activator of transcription (STAT) in response to IL-1β in clonal insulin-secreting cells. Moreover, IL-1β activates a short isoform of STAT-3 that potently stimulates transcription. Immunoprecipitation studies reveal an interaction between the activated STAT-3 and the IL-1 receptor accessory protein indicating an association between the two signaling pathways. This may be a novel point of transduction cross talk and an additional mechanism utilised by IL-1β in the pancreatic β-cell during the process of type 1 diabetes.</div>
</front>
</TEI>
<istex>
<corpusName>elsevier</corpusName>
<author>
<json:item>
<name>Nicholas M. Morton</name>
<affiliations>
<json:string>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</json:string>
</affiliations>
</json:item>
<json:item>
<name>Rolf P. de Groot</name>
<affiliations>
<json:string>Department of Pulmonary Diseases, University Hospital Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands</json:string>
</affiliations>
</json:item>
<json:item>
<name>Michael A. Cawthorne</name>
<affiliations>
<json:string>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</json:string>
</affiliations>
</json:item>
<json:item>
<name>Valur Emilsson</name>
<affiliations>
<json:string>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</json:string>
<json:string>Corresponding author. Fax: (44) (1280) 822245. E-mail: valur.emilsson@buckingham.ac.uk</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Interleukin 1β</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Signal transducer and activator of transcription 3</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Clonal β-cell</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Interleukin 1 receptor accessory protein</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IL-1β, interleukin-1β</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IL-1RI, interleukin-1 receptor type I</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IL-1RAcP, interleukin-1 receptor accessory protein</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>STAT, signal transducer and activator of transcription</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>JAK, Janus kinase</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IBMX, isobutyl methyl xanthine</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>GAS, interferon-γ-activated sequence</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>CAT, chloramphenicol acetyltransferase</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IRE, interferon-γ/interleukin-6 response element</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ICAM, intercellular adhesion molecule</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>IRF-1, interferon response factor-1</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>SIE, SIS inducible element</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cAMP, cyclic adenosine monophosphate</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>GLP-1, glucagon-like peptide 1</value>
</json:item>
</subject>
<language>
<json:string>eng</json:string>
</language>
<abstract>Interleukin-1β (IL-1β) is a potent inflammatory cytokine involved in type 1 diabetes and acts through defined IL-1β signaling pathways. In the present work we describe induction of DNA binding activity to signal transducer and activator of transcription (STAT) in response to IL-1β in clonal insulin-secreting cells. Moreover, IL-1β activates a short isoform of STAT-3 that potently stimulates transcription. Immunoprecipitation studies reveal an interaction between the activated STAT-3 and the IL-1 receptor accessory protein indicating an association between the two signaling pathways. This may be a novel point of transduction cross talk and an additional mechanism utilised by IL-1β in the pancreatic β-cell during the process of type 1 diabetes.</abstract>
<qualityIndicators>
<score>4.405</score>
<pdfVersion>1.2</pdfVersion>
<pdfPageSize>588 x 804 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>18</keywordCount>
<abstractCharCount>752</abstractCharCount>
<pdfWordCount>3097</pdfWordCount>
<pdfCharCount>19181</pdfCharCount>
<pdfPageCount>4</pdfPageCount>
<abstractWordCount>109</abstractWordCount>
</qualityIndicators>
<title>Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells</title>
<pii>
<json:string>S0014-5793(98)01623-8</json:string>
</pii>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<volume>442</volume>
<pii>
<json:string>S0014-5793(00)X0201-3</json:string>
</pii>
<pages>
<last>60</last>
<first>57</first>
</pages>
<issn>
<json:string>0014-5793</json:string>
</issn>
<issue>1</issue>
<genre></genre>
<language>
<json:string>unknown</json:string>
</language>
<title>FEBS Letters</title>
<publicationDate>1999</publicationDate>
</host>
<categories>
<wos>
<json:string>BIOCHEMISTRY & MOLECULAR BIOLOGY</json:string>
<json:string>BIOPHYSICS</json:string>
<json:string>CELL BIOLOGY</json:string>
</wos>
</categories>
<publicationDate>1998</publicationDate>
<copyrightDate>1999</copyrightDate>
<doi>
<json:string>10.1016/S0014-5793(98)01623-8</json:string>
</doi>
<id>D7F2399CD8FED943471BB11ED805B8AFB48B84A4</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/D7F2399CD8FED943471BB11ED805B8AFB48B84A4/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/D7F2399CD8FED943471BB11ED805B8AFB48B84A4/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/D7F2399CD8FED943471BB11ED805B8AFB48B84A4/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a">Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability>
<p>ELSEVIER</p>
</availability>
<date>1999</date>
</publicationStmt>
<notesStmt>
<note type="content">Fig. 1: IL-1β induces time- and dose-dependent DNA binding activity on the IRF-1 STAT consensus. IL-1β (50 pg/ml)-induced STAT DNA binding to the IRF-1 is observed by 5 min, peaks at 15–20 min and returns to basal by 30 min (upper panel). The STAT DNA binding is observed over the concentration range of 0.5–500 pg/ml (upper panel). Supershift analyses of IL-1β (50 pg/ml)-induced STAT DNA binding to the IRF-1 with C-terminal antibodies to STAT-1, -2, -3, -5a, -5b and -6 are shown in the bottom panel. The arrows point at the STAT DNA complex.</note>
<note type="content">Fig. 2: IL-1β induces STAT-3 DNA binding activity. An appropriate time (15 min) and dose of IL-1β (50 pg/ml) was selected from results on the IRF-1 probe, to study the effects of IL-1β on m67SIE binding activity. IL-1β (50 pg/ml) induced the STAT DNA binding activity of the m67SIE probe that is known to bind STAT-3 avidly. The arrow points at the STAT DNA band shift.</note>
<note type="content">Fig. 3: IL-1β causes a time-dependent induction of a STAT-3 immunoreactive protein in RINm5F nuclear extracts. RINm5F were pre-incubated in serum-free medium for 24 h and then exposed to IL-1β (50 pg/ml) for the times indicated below the lanes. Time-dependent induction of a protein complex (∼67 kDa) that cross-reacts with a phospho (Y705) STAT-3 antibody. Time-dependent induction of a STAT-3 N-terminal immunoreactive protein that co-migrates with the tyrosine phosphorylated STAT-3 species at approximately 67 kDa.</note>
<note type="content">Fig. 4: IL-1β induces transcriptional activation from the IRE-CAT. RINm5F cells were transiently transfected with reporter plasmids driven by the STAT consensus promoter element indicated below the axis. After a period of serum starvation, the RINm5F were exposed to IL-1β (50 pg/ml) for 12 h and then assessed for induction of CAT activity. The IRE-CAT reporter construct was strongly induced whereas a slight induction at the GAS-CAT and no induction from a control plasmid pBL or βCAS-CAT constructs were observed.</note>
<note type="content">Fig. 5: IL-1β induces the interaction of activated STAT-3 with the IL-1RAcP. RINm5F cells were treated with IL-1β (50 pg/ml) for the indicated time and then lysed. Immunoprecipitation was performed on whole cell lysates with an anti-phospho STAT-3 Y705 antibody. Identical immunoprecipitates were then probed with either an N-terminal directed STAT-3 antibody or an anti-IL-1RAcP monoclonal antibody on separate gels. IL-1β treatment increases the association with a peak at 2 min that rapidly declines by 10 min.</note>
<note type="content">Fig. 6: Increasing intracellular cAMP attenuates the IL-1β-inducible STAT DNA binding. The cells were pre-incubated in serum-free medium and then given a second pre-incubation for 15 min with 10 nM GLP-1 or 10 μM forskolin/50 μM IBMX. IL-1β (50 pg/ml) was then added in the presence of the compounds and the nuclear extracts isolated. The nuclear extracts were then incubated with [γ-32P]ATP end-labelled m67SIE probe and the complexes separated on 4% PAGE gels and analysed by autoradiography.</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a">Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells</title>
<author>
<persName>
<forename type="first">Nicholas M.</forename>
<surname>Morton</surname>
</persName>
<affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</affiliation>
</author>
<author>
<persName>
<forename type="first">Rolf P.</forename>
<surname>de Groot</surname>
</persName>
<affiliation>Department of Pulmonary Diseases, University Hospital Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands</affiliation>
</author>
<author>
<persName>
<forename type="first">Michael A.</forename>
<surname>Cawthorne</surname>
</persName>
<affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</affiliation>
</author>
<author>
<persName>
<forename type="first">Valur</forename>
<surname>Emilsson</surname>
</persName>
<email>valur.emilsson@buckingham.ac.uk</email>
<affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</affiliation>
</author>
</analytic>
<monogr>
<title level="j">FEBS Letters</title>
<title level="j" type="abbrev">FEBS</title>
<idno type="pISSN">0014-5793</idno>
<idno type="PII">S0014-5793(00)X0201-3</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1998"></date>
<biblScope unit="volume">442</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="57">57</biblScope>
<biblScope unit="page" to="60">60</biblScope>
</imprint>
</monogr>
<idno type="istex">D7F2399CD8FED943471BB11ED805B8AFB48B84A4</idno>
<idno type="DOI">10.1016/S0014-5793(98)01623-8</idno>
<idno type="PII">S0014-5793(98)01623-8</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1999</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Interleukin-1β (IL-1β) is a potent inflammatory cytokine involved in type 1 diabetes and acts through defined IL-1β signaling pathways. In the present work we describe induction of DNA binding activity to signal transducer and activator of transcription (STAT) in response to IL-1β in clonal insulin-secreting cells. Moreover, IL-1β activates a short isoform of STAT-3 that potently stimulates transcription. Immunoprecipitation studies reveal an interaction between the activated STAT-3 and the IL-1 receptor accessory protein indicating an association between the two signaling pathways. This may be a novel point of transduction cross talk and an additional mechanism utilised by IL-1β in the pancreatic β-cell during the process of type 1 diabetes.</p>
</abstract>
<textClass>
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>Interleukin 1β</term>
</item>
<item>
<term>Signal transducer and activator of transcription 3</term>
</item>
<item>
<term>Clonal β-cell</term>
</item>
<item>
<term>Interleukin 1 receptor accessory protein</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="keyword">
<list>
<head>Abbreviations</head>
<item>
<term>IL-1β, interleukin-1β</term>
</item>
<item>
<term>IL-1RI, interleukin-1 receptor type I</term>
</item>
<item>
<term>IL-1RAcP, interleukin-1 receptor accessory protein</term>
</item>
<item>
<term>STAT, signal transducer and activator of transcription</term>
</item>
<item>
<term>JAK, Janus kinase</term>
</item>
<item>
<term>IBMX, isobutyl methyl xanthine</term>
</item>
<item>
<term>GAS, interferon-γ-activated sequence</term>
</item>
<item>
<term>CAT, chloramphenicol acetyltransferase</term>
</item>
<item>
<term>IRE, interferon-γ/interleukin-6 response element</term>
</item>
<item>
<term>ICAM, intercellular adhesion molecule</term>
</item>
<item>
<term>IRF-1, interferon response factor-1</term>
</item>
<item>
<term>SIE, SIS inducible element</term>
</item>
<item>
<term>cAMP, cyclic adenosine monophosphate</term>
</item>
<item>
<term>GLP-1, glucagon-like peptide 1</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="1998-11-13">Received</change>
<change when="1998">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/D7F2399CD8FED943471BB11ED805B8AFB48B84A4/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Elsevier, elements deleted: ce:floats; body; tail">
<istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType">
<istex:entity SYSTEM="gr1" NDATA="IMAGE" name="gr1"></istex:entity>
<istex:entity SYSTEM="gr2" NDATA="IMAGE" name="gr2"></istex:entity>
<istex:entity SYSTEM="gr3" NDATA="IMAGE" name="gr3"></istex:entity>
<istex:entity SYSTEM="gr4" NDATA="IMAGE" name="gr4"></istex:entity>
<istex:entity SYSTEM="gr5" NDATA="IMAGE" name="gr5"></istex:entity>
<istex:entity SYSTEM="gr6" NDATA="IMAGE" name="gr6"></istex:entity>
</istex:docType>
<istex:document>
<converted-article version="4.5.2" docsubtype="fla">
<item-info>
<jid>FEBS</jid>
<aid>21368</aid>
<ce:pii>S0014-5793(98)01623-8</ce:pii>
<ce:doi>10.1016/S0014-5793(98)01623-8</ce:doi>
<ce:copyright year="1999" type="society">Federation of European Biochemical Societies</ce:copyright>
</item-info>
<head>
<ce:title>Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells</ce:title>
<ce:author-group>
<ce:author>
<ce:given-name>Nicholas M.</ce:given-name>
<ce:surname>Morton</ce:surname>
<ce:cross-ref refid="AFF1">a</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Rolf P.</ce:given-name>
<ce:surname>de Groot</ce:surname>
<ce:cross-ref refid="AFF2">b</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Michael A.</ce:given-name>
<ce:surname>Cawthorne</ce:surname>
<ce:cross-ref refid="AFF1">a</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Valur</ce:given-name>
<ce:surname>Emilsson</ce:surname>
<ce:cross-ref refid="AFF1">a</ce:cross-ref>
<ce:cross-ref refid="CORR1">*</ce:cross-ref>
</ce:author>
<ce:affiliation id="AFF1">
<ce:label>a</ce:label>
<ce:textfn>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF2">
<ce:label>b</ce:label>
<ce:textfn>Department of Pulmonary Diseases, University Hospital Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands</ce:textfn>
</ce:affiliation>
<ce:correspondence id="CORR1">
<ce:label>*</ce:label>
<ce:text>Corresponding author. Fax: (44) (1280) 822245. E-mail: valur.emilsson@buckingham.ac.uk</ce:text>
</ce:correspondence>
</ce:author-group>
<ce:date-received day="13" month="11" year="1998"></ce:date-received>
<ce:abstract>
<ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec>
<ce:simple-para>Interleukin-1β (IL-1β) is a potent inflammatory cytokine involved in type 1 diabetes and acts through defined IL-1β signaling pathways. In the present work we describe induction of DNA binding activity to signal transducer and activator of transcription (STAT) in response to IL-1β in clonal insulin-secreting cells. Moreover, IL-1β activates a short isoform of STAT-3 that potently stimulates transcription. Immunoprecipitation studies reveal an interaction between the activated STAT-3 and the IL-1 receptor accessory protein indicating an association between the two signaling pathways. This may be a novel point of transduction cross talk and an additional mechanism utilised by IL-1β in the pancreatic β-cell during the process of type 1 diabetes.</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
<ce:keywords class="keyword">
<ce:section-title>Keywords</ce:section-title>
<ce:keyword>
<ce:text>Interleukin 1β</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>Signal transducer and activator of transcription 3</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>Clonal β-cell</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>Interleukin 1 receptor accessory protein</ce:text>
</ce:keyword>
</ce:keywords>
<ce:keywords class="abr">
<ce:section-title>Abbreviations</ce:section-title>
<ce:keyword>
<ce:text>IL-1β, interleukin-1β</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>IL-1RI, interleukin-1 receptor type I</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>IL-1RAcP, interleukin-1 receptor accessory protein</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>STAT, signal transducer and activator of transcription</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>JAK, Janus kinase</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>IBMX, isobutyl methyl xanthine</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>GAS, interferon-γ-activated sequence</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>CAT, chloramphenicol acetyltransferase</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>IRE, interferon-γ/interleukin-6 response element</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>ICAM, intercellular adhesion molecule</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>IRF-1, interferon response factor-1</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>SIE, SIS inducible element</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>cAMP, cyclic adenosine monophosphate</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>GLP-1, glucagon-like peptide 1</ce:text>
</ce:keyword>
</ce:keywords>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo>
<title>Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<title>Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">Nicholas M.</namePart>
<namePart type="family">Morton</namePart>
<affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Rolf P.</namePart>
<namePart type="family">de Groot</namePart>
<affiliation>Department of Pulmonary Diseases, University Hospital Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Michael A.</namePart>
<namePart type="family">Cawthorne</namePart>
<affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Valur</namePart>
<namePart type="family">Emilsson</namePart>
<affiliation>Clore Laboratory, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK</affiliation>
<affiliation>Corresponding author. Fax: (44) (1280) 822245. E-mail: valur.emilsson@buckingham.ac.uk</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article"></genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1998</dateIssued>
<dateCaptured encoding="w3cdtf">1998-11-13</dateCaptured>
<copyrightDate encoding="w3cdtf">1999</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">Interleukin-1β (IL-1β) is a potent inflammatory cytokine involved in type 1 diabetes and acts through defined IL-1β signaling pathways. In the present work we describe induction of DNA binding activity to signal transducer and activator of transcription (STAT) in response to IL-1β in clonal insulin-secreting cells. Moreover, IL-1β activates a short isoform of STAT-3 that potently stimulates transcription. Immunoprecipitation studies reveal an interaction between the activated STAT-3 and the IL-1 receptor accessory protein indicating an association between the two signaling pathways. This may be a novel point of transduction cross talk and an additional mechanism utilised by IL-1β in the pancreatic β-cell during the process of type 1 diabetes.</abstract>
<note type="content">Fig. 1: IL-1β induces time- and dose-dependent DNA binding activity on the IRF-1 STAT consensus. IL-1β (50 pg/ml)-induced STAT DNA binding to the IRF-1 is observed by 5 min, peaks at 15–20 min and returns to basal by 30 min (upper panel). The STAT DNA binding is observed over the concentration range of 0.5–500 pg/ml (upper panel). Supershift analyses of IL-1β (50 pg/ml)-induced STAT DNA binding to the IRF-1 with C-terminal antibodies to STAT-1, -2, -3, -5a, -5b and -6 are shown in the bottom panel. The arrows point at the STAT DNA complex.</note>
<note type="content">Fig. 2: IL-1β induces STAT-3 DNA binding activity. An appropriate time (15 min) and dose of IL-1β (50 pg/ml) was selected from results on the IRF-1 probe, to study the effects of IL-1β on m67SIE binding activity. IL-1β (50 pg/ml) induced the STAT DNA binding activity of the m67SIE probe that is known to bind STAT-3 avidly. The arrow points at the STAT DNA band shift.</note>
<note type="content">Fig. 3: IL-1β causes a time-dependent induction of a STAT-3 immunoreactive protein in RINm5F nuclear extracts. RINm5F were pre-incubated in serum-free medium for 24 h and then exposed to IL-1β (50 pg/ml) for the times indicated below the lanes. Time-dependent induction of a protein complex (∼67 kDa) that cross-reacts with a phospho (Y705) STAT-3 antibody. Time-dependent induction of a STAT-3 N-terminal immunoreactive protein that co-migrates with the tyrosine phosphorylated STAT-3 species at approximately 67 kDa.</note>
<note type="content">Fig. 4: IL-1β induces transcriptional activation from the IRE-CAT. RINm5F cells were transiently transfected with reporter plasmids driven by the STAT consensus promoter element indicated below the axis. After a period of serum starvation, the RINm5F were exposed to IL-1β (50 pg/ml) for 12 h and then assessed for induction of CAT activity. The IRE-CAT reporter construct was strongly induced whereas a slight induction at the GAS-CAT and no induction from a control plasmid pBL or βCAS-CAT constructs were observed.</note>
<note type="content">Fig. 5: IL-1β induces the interaction of activated STAT-3 with the IL-1RAcP. RINm5F cells were treated with IL-1β (50 pg/ml) for the indicated time and then lysed. Immunoprecipitation was performed on whole cell lysates with an anti-phospho STAT-3 Y705 antibody. Identical immunoprecipitates were then probed with either an N-terminal directed STAT-3 antibody or an anti-IL-1RAcP monoclonal antibody on separate gels. IL-1β treatment increases the association with a peak at 2 min that rapidly declines by 10 min.</note>
<note type="content">Fig. 6: Increasing intracellular cAMP attenuates the IL-1β-inducible STAT DNA binding. The cells were pre-incubated in serum-free medium and then given a second pre-incubation for 15 min with 10 nM GLP-1 or 10 μM forskolin/50 μM IBMX. IL-1β (50 pg/ml) was then added in the presence of the compounds and the nuclear extracts isolated. The nuclear extracts were then incubated with [γ-32P]ATP end-labelled m67SIE probe and the complexes separated on 4% PAGE gels and analysed by autoradiography.</note>
<subject>
<genre>Keywords</genre>
<topic>Interleukin 1β</topic>
<topic>Signal transducer and activator of transcription 3</topic>
<topic>Clonal β-cell</topic>
<topic>Interleukin 1 receptor accessory protein</topic>
</subject>
<subject>
<genre>Abbreviations</genre>
<topic>IL-1β, interleukin-1β</topic>
<topic>IL-1RI, interleukin-1 receptor type I</topic>
<topic>IL-1RAcP, interleukin-1 receptor accessory protein</topic>
<topic>STAT, signal transducer and activator of transcription</topic>
<topic>JAK, Janus kinase</topic>
<topic>IBMX, isobutyl methyl xanthine</topic>
<topic>GAS, interferon-γ-activated sequence</topic>
<topic>CAT, chloramphenicol acetyltransferase</topic>
<topic>IRE, interferon-γ/interleukin-6 response element</topic>
<topic>ICAM, intercellular adhesion molecule</topic>
<topic>IRF-1, interferon response factor-1</topic>
<topic>SIE, SIS inducible element</topic>
<topic>cAMP, cyclic adenosine monophosphate</topic>
<topic>GLP-1, glucagon-like peptide 1</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>FEBS Letters</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>FEBS</title>
</titleInfo>
<genre type="Journal">journal</genre>
<originInfo>
<dateIssued encoding="w3cdtf">19990108</dateIssued>
</originInfo>
<identifier type="ISSN">0014-5793</identifier>
<identifier type="PII">S0014-5793(00)X0201-3</identifier>
<part>
<date>19990108</date>
<detail type="volume">
<number>442</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>1</number>
<caption>no.</caption>
</detail>
<extent unit="issue pages">
<start>1</start>
<end>122</end>
</extent>
<extent unit="pages">
<start>57</start>
<end>60</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">D7F2399CD8FED943471BB11ED805B8AFB48B84A4</identifier>
<identifier type="DOI">10.1016/S0014-5793(98)01623-8</identifier>
<identifier type="PII">S0014-5793(98)01623-8</identifier>
<accessCondition type="use and reproduction" contentType="">© 1999Federation of European Biochemical Societies</accessCondition>
<recordInfo>
<recordContentSource>ELSEVIER</recordContentSource>
<recordOrigin>Federation of European Biochemical Societies, ©1999</recordOrigin>
</recordInfo>
</mods>
</metadata>
<enrichments>
<istex:catWosTEI uri="https://api.istex.fr/document/D7F2399CD8FED943471BB11ED805B8AFB48B84A4/enrichments/catWos">
<teiHeader>
<profileDesc>
<textClass>
<classCode scheme="WOS">BIOCHEMISTRY & MOLECULAR BIOLOGY</classCode>
<classCode scheme="WOS">BIOPHYSICS</classCode>
<classCode scheme="WOS">CELL BIOLOGY</classCode>
</textClass>
</profileDesc>
</teiHeader>
</istex:catWosTEI>
</enrichments>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/SchutzV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D73 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000D73 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    SchutzV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:D7F2399CD8FED943471BB11ED805B8AFB48B84A4
   |texte=   Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Mon Feb 8 17:34:10 2021. Site generation: Mon Feb 8 17:41:23 2021